文献速递糖尿病肥胖与代谢综合征

可解释机器学习框架揭示与2型糖尿病相关的稳健肠道微生物组特征

Interpretable Machine Learning Framework Reveals Robust Gut Microbiome Features Associated With Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2020-12-07

研究采用可解释机器学习框架,在三个中国队列的横断面分析中识别2型糖尿病相关肠道微生物特征,构建了包含14个微生物特征的微生物风险评分(MRS)。MRS在三个队列中均与2型糖尿病一致相关,并与未来血糖增量正相关,且与多种肠道菌群来源的血代谢物相关;动物实验进一步证实了MRS与2型糖尿病的关系。体脂分布是调节肠道微生物组-2型糖尿病关系的关键因素。

要点

  • 基于14个微生物特征的MRS与2型糖尿病风险一致相关。
  • MRS与未来血糖增量正相关,并与菌群来源血代谢物相关。
  • 体脂分布是调节肠道微生物组与2型糖尿病关系的关键因素。

核心结论

  • 研究揭示了一组与2型糖尿病风险和未来血糖增量相关的核心肠道微生物组特征。

研究设计与样本

  • 采用可解释机器学习框架,在三个中国队列的横断面分析中识别2型糖尿病相关肠道微生物特征。
  • 发现队列n=1,832(270例2型糖尿病),验证队列1 n=203(48例),验证队列2 n=7,009(608例)。
  • 在249名无2型糖尿病参与者中前瞻性检验MRS与血糖增量的关联,在n=1,016中评估MRS与宿主血代谢物的相关性。
  • 将不同MRS水平的人粪便样本移植到无菌小鼠以验证MRS-2型糖尿病关系。
  • 在n=1,832中检验人口学、肥胖和饮食因素与MRS的前瞻性关联。

主要发现

  • MRS(包含14个微生物特征)在三个队列中与2型糖尿病一致相关。
  • MRS每变化1单位的风险比分别为1.28(95%CI 1.23-1.33)、1.23(95%CI 1.13-1.34)和1.12(95%CI 1.06-1.18)。
  • MRS与未来血糖增量正相关(P < 0.05)。
  • MRS与多种肠道 microbiota 来源的血代谢物相关。
  • 动物研究进一步证实了MRS与2型糖尿病的关系。

临床怎么用

  • MRS可作为评估2型糖尿病风险的微生物组指标,并提示体脂分布是干预调节的关键因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify the core gut microbial features associated with type 2 diabetes risk and potential demographic, adiposity, and dietary factors associated with these features. RESEARCH DESIGN AND METHODS: We used an interpretable machine learning framework to identify the type 2 diabetes-related gut microbiome features in the cross-sectional analyses of three Chinese cohorts: one discovery cohort (n = 1,832, 270 cases of type 2 diabetes) and two validation cohorts (cohort 1: n = 203, 48 cases; cohort 2: n = 7,009, 608 cases). We constructed a microbiome risk score (MRS) with the identified features. We examined the prospective association of the MRS with glucose increment in 249 participants without type 2 diabetes and assessed the correlation between the MRS and host blood metabolites (n = 1,016). We transferred human fecal samples with different MRS levels to germ-free mice to confirm the MRS-type 2 diabetes relationship. We then examined the prospective association of demographic, adiposity, and dietary factors with the MRS (n = 1,832). RESULTS: The MRS (including 14 microbial features) consistently associated with type 2 diabetes, with risk ratio for per 1-unit change in MRS 1.28 (95% CI 1.23-1.33), 1.23 (1.13-1.34), and 1.12 (1.06-1.18) across three cohorts. The MRS was positively associated with future glucose increment (P < 0.05) and was correlated with a variety of gut microbiota-derived blood metabolites. Animal study further confirmed the MRS-type 2 diabetes relationship. Body fat distribution was found to be a key factor modulating the gut microbiome-type 2 diabetes relationship. CONCLUSIONS: Our results reveal a core set of gut microbiome features associated with type 2 diabetes risk and future glucose increment.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Gou W, Ling CW, He Y, et al. Interpretable Machine Learning Framework Reveals Robust Gut Microbiome Features Associated With Type 2 Diabetes. Diabetes Care. 2020. PMID: 33288652. doi:10.2337/dc20-1536

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。